Northern Trust
LUCD icon

Northern Trust’s Lucid Diagnostics LUCD Stock Holding History

Northern Trust’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$771K Buy
670,585
+33,571
+5% +$42.7K ﹤0.01% 3448
2025
Q4 		$694K Buy
637,014
+133,269
+26% +$149K ﹤0.01% 3535
2025
Q3 		$509K Sell
503,745
-25,674
-5% -$28K ﹤0.01% 3636
2025
Q2 		$609K Buy
529,419
+487,639
+1,167% +$630K ﹤0.01% 3592
2025
Q1 		$62.3K Buy
41,780
+28,652
+218% +$34.4K ﹤0.01% 4197
2024
Q4 		$10.7K Hold
13,128
– – ﹤0.01% 4420
2024
Q3 		$10.7K Hold
13,128
– – ﹤0.01% 4376
2024
Q2 		$10.8K Sell
13,128
-17
-0.1% -$14 ﹤0.01% 4375
2024
Q1 		$10.6K Buy
+13,145
New +$17.1K ﹤0.01% 4385
2022
Q2 		– Sell
-40,834
Closed -$137K – 4787
2022
Q1 		$137K Buy
40,834
+2,182
+6% +$7.97K ﹤0.01% 4255
2021
Q4 		$207K Buy
+38,652
New +$314K ﹤0.01% 4184

Other funds holding LUCD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Northern Trust's LUCD Position: Q1 2026 in Review

Northern Trust increased its Lucid Diagnostics (LUCD) stake by 5.3% in Q1 2026, buying an estimated $42.7K and bringing the position to 670,585 shares worth $771K. The position accounts for ﹤0.01% of the portfolio, ranked #3448.

Northern Trust first reported a position in LUCD in Q4 2021 and has held it in 11 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Northern Trust held 670,585 shares of Lucid Diagnostics worth $771K as of Q1 2026.
  • Northern Trust bought 33,571 Lucid Diagnostics shares in Q1 2026, an estimated $42.7K.
  • Lucid Diagnostics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3448 holding.
  • Northern Trust first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 11 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.